Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation System (SNS), a wireless, implantable brain-computer interface designed for ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

Learn how to lead like a soccer captain. CEO Ciaran McArdle shares his playbook for tailored leadership, clear boundaries, ...

The Zika virus epidemic that began in Brazil in 2015 and quickly spread to other countries caused an unprecedented flood of ...

The orbitofrontal cortex (OFC) is critical to identifying task structure and to generalizing appropriately across task states with similar underlying or hidden causes. This capability is at the heart ...

Today at CES 2026, Sumbu announced its Exo-S3 line of dual-vector exoskeletons designed for the general public: the Exo-S3, Exo-S3 Pro and Exo-S3 Ultra. The series is the world's first commercially ...

Douglas Elliman CEO on creating a culture of “winning,” his relationship with Howard Lorber and his non-negotiables ...

"Cleanup will take at least 30 days" because that's how long leptospirosis can live in soil, said the city, calling it an ...

Artificial intelligence has learned to talk, draw and code, but it still struggles with something children master in ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...